Harpoon Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Harpoon Therapeutics, Inc.
CIK #0001708493
EDGAR Form CIK 2011 - 2025
10-K [0001708493]
10-Q [0001708493]
3 [0001708493]
4 [0001708493]
8-K [0001708493]
D [0001708493]
SC 13D [0001708493]
SC 13G [0001708493]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glazer Capital LLC Harpoon Therapeutics Inc [2024-03-18]
Gamco Investors Inc ET AL Harpoon Therapeutics Inc [2024-02-27]
Vanguard Group Inc Harpoon Therapeutics Inc [2024-02-13]
Merck Sharp & Dohme LLC Harpoon Therapeutics Inc [2024-01-18]
Citadel Advisors LLC Harpoon Therapeutics Inc [2023-11-06]
Cormorant Asset Management LP Harpoon Therapeutics Inc [2023-11-06]
RA Capital Management LP Harpoon Therapeutics Inc [2023-11-06]
Commodore Capital LP Harpoon Therapeutics Inc [2023-11-03]
Soleus Private Equity Fund III LP Harpoon Therapeutics Inc [2023-10-26]
Artal International SCA Harpoon Therapeutics Inc [2023-03-31]
View All
Form 3/4/5 Subject 2011 - 2025
Harpoon Therapeutics, Inc.
Eastland Julia Marie
Lanza Frank J
Robbins Andrew R
Drachman Jonathan G
Chin Mark
Myers Scott Dunseth
Walker Luke Nathaniel
Hunt Ronald
New Leaf Biopharma Opportunities II, L.P.
View All
Terms | Privacy | Guide
tony@aum13f.com